Specipig has obtained a certificate of compliance with the principles of Good Laboratory Practices (GLP) from the Department of Health (Government of Catalonia) for conducting trials of toxicity, tolerance and biocompatibility in drugs for human use and healthcare devices.

"This recognition of quality is a step forward in the company's internationalisation process. In 2017 we hope to move into markets such as the United Kingdom and Italy" explains Jaume Amat, CEO of Specipig and member of the board of CataloniaBio.

This certification has been awarded as the result of implementing a wider quality assurance system, allowing the company to position itself "as the first Contract Research Organisation in Europe specialising in the swine model and GLP certified, offering services ranging from breeding of the animal model to preclinical CRO services” explained Judit Amposta, Specipig’s Director of Quality Assurance Unit.

More information on Specipig website

Photo: Judit Amposta and Jaume Amat - © Specipig